✦ LIBER ✦

Analysis of serum cancer procoagulant activity and its possible use as a tumor marker

✍ Scribed by Stuart G. Gordon; Beverly Benson

Book ID: 119037504
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 789 KB
Volume: 56
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(89)90256-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum dipeptidyl peptidase activities as

Serum dipeptidyl peptidase activities as a possible marker of oral cancer

✍ Masahiro Urade; Masataka Komatsu; Minoru Yamaoka; Katsuhiko Fukasawa; Minoru Har 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Serum carcino-embryonic antigen (CEA) an

Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirs

✍ Loeser, Andreas; Neumann, Michael; Kocot, Arkardius; Vergho, Daniel C.; Spahn, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Serum p53 and bladder cancer: can serum

Serum p53 and bladder cancer: can serum p53 be used as a tumor marker?

✍ Malviya, Vibhav ;Singh, Harbans ;Dwivedi, U. S. ;Usha, � ;Singh, P. B. 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 168 KB

Clinical use of serum TRA-1-60 as tumor

Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer

✍ Henrik Lajer; Gedske Daugaard; Anna-Maria Andersson; Niels Erik Skakkebæk 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract TRA‐1‐60 antigen has been related to the presence of embryonal germ cell carcinoma (EC) and carcinoma __in situ__. Our study further investigated the clinical efficacy of TRA‐1‐60 as a serum tumor marker for germ cell cancer in the testis. Three groups of patients with germ cell tumors

SERUM CYFRA 21–1 IN PATIENTS WITH INVASI

SERUM CYFRA 21–1 IN PATIENTS WITH INVASIVE BLADDER CANCER AND ITS RELEVANCE AS A TUMOR MARKER DURING CHEMOTHERAPY

✍ ANDREADIS, CHARALAMPOS; TOULOUPIDIS, STAVROS; GALAKTIDOU, GRAMMATI; KORTSARIS, A 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 985 KB

Clinical evaluation of serum tumor-assoc

Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients

✍ Fiorella Guadagni; Mario Roselli; Teresa Amato; Maurizio Cosimelli; Ernesto Mann 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

A novel tumor marker, tumor-associated glycoprotein-72 (TAG-72), has been identified using monoclonal antibody (MAb) B72.3. Using immunohistochemical techniques, TAG-72 has been found in carcinomas of various origin including colon, stomach, breast, lung, prostate, and ovary, as well as in body flui